Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Systematic Assessment of GATA2 Genetic Variation Reveals the Presence of Novel Disease-Causing Synonymous Exonic Mutations

Blood (2017) 130 (Supplement 1): 2449.

https://doi.org/10.1182/blood.V130.Suppl_1.2449.2449

Published: 2017

Journal Articles

Differences in Infection Prophylaxis between Pediatric AML Study Groups within the International BFM Study Group

Kim Klein, MD MSc, Henrik Hasle, MD PhD, Jonas Abrahamsson, MD PhD, Barbara De Moerloose, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2017) 130 (Supplement 1): 2104.

https://doi.org/10.1182/blood.V130.Suppl_1.2104.2104

Published: 2017

Journal Articles

Constitutional Ring Chromosome 21 Predisposes to Acute Lymphoblastic Leukaemia (ALL) with iAMP21

Claire Schwab, Eigil Kjeldsen, MD DMSc, Nyla A. Heerema, PhD, Andrew Carroll, PhD, Matthew Bashton, PhD, Sarra Ryan, PhD, Anthony V. Moorman, PhD, Stephen P. Hunger, MD, Mignon L. Loh, MD, Henrik Hasle, MD PhD, Christine J Harrison, PhD FRCPath

Blood (2017) 130 (Supplement 1): 3978.

https://doi.org/10.1182/blood.V130.Suppl_1.3978.3978

Published: 2017

Journal Articles

Constitutional SAMD9L Mutations Cause Familial Myelodisplastic Syndrome with Monosomy 7 and Stable Revertant Mosaicism

Blood (2017) 130 (Supplement 1): 1672.

https://doi.org/10.1182/blood.V130.Suppl_1.1672.1672

Published: 2017

Journal Articles

Characteristics and Outcomes of Pediatric Patients with t(16;16)-AML: Results of a Case Series By the International BFM Study Group

Kim Klein, MD MSc, Valerie de Haas, MD PhD, Jonas Abrahamsson, MD PhD, Todd A Alonzo, PhD, Brenda Gibson, MD PhD, Christine J Harrison, PhD FRCPath, Henrik Hasle, MD PhD, Betsy A Hirsch, PhD, Guy Leverger, MD PhD, Franco Locatelli, MD PhD, Susana C. Raimondi, PhD, Jeffrey E Rubnitz, MD PhD, Dirk Reinhardt, MD PhD, Daisuke Tomizawa, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2017) 130 (Supplement 1): 2671.

https://doi.org/10.1182/blood.V130.Suppl_1.2671.2671

Published: 2017

Journal Articles

Obesity Is Associated with Favorable Cytogenetic Abnormalities in Pediatric Acute Myeloid Leukemia

Ditte Juel Adolfsen Løhmann, MD, Jonas Abrahamsson, MD PhD, Shau-Yin Ha, MD PhD, Olafur G. Jonsson, MD PhD, Gertjan J.L. Kaspers, MD PhD, Minna M Koskenvuo, MD PhD, Birgitte Lausen, MD PhD, Barbara De Moerloose, MD PhD, Josefine Palle, MD PhD, Bernward Zeller, MD PhD, Henrik Hasle, MD PhD, Lillian Sung, MD PhD

Blood (2017) 130 (Supplement 1): 1302.

https://doi.org/10.1182/blood.V130.Suppl_1.1302.1302

Published: 2017

Journal Articles

Effect of Age and Weight on Toxicity and Survival in Pediatric Acute Myeloid Leukemia

Ditte Juel Adolfsen Løhmann, MD, Jonas Abrahamson, Shau Yin Ha, Ólafur G. Jónsson, Minna Koskenvuo, Birgitte Lausen, MD, Josefine Palle, Bernward Zeller, Henrik Hasle, MD PhD

Blood (2015) 126 (23): 3745.

https://doi.org/10.1182/blood.V126.23.3745.3745

Published: 2015

Journal Articles

Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study

Oussama Abla, MD, Raul C. Ribeiro, MD, Anna Maria Testi, MD, Pau Montesinos Fernández, MD, Ursula Creutzig, MD, Lillian Sung, MD PhD, Giancarlo Di Giuseppe, BSc, Derek Stephens, MSc, Henrik Hasle, MD PhD, Gertjan J.L. Kaspers, MD PhD, Luciano Dalla-Pozza, MB BS FRACP, Alvaro Lassaletta, MD, Martin S. Tallman, MD, Franco Locatelli, MD, Dirk Reinhardt, MD, Johann Hitzler, MD FRCP (C), FAAP, Miguel A. Sanz, MD PhD

Blood (2015) 126 (23): 172.

https://doi.org/10.1182/blood.V126.23.172.172

Published: 2015

Journal Articles

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Anna Maria Testi, MD, Andrea Pession, MD, David Grimwade, PhD FRCPath, Daniela Diverio, PhD, Christine Ragu, PhD, Sarah Elitzur, MD, Alcira Fynn, MD, Henrik Hasle, MD PhD, Jutte Van der Werff ten Bosch, MD PhD, Owen Smith, MD, Brenda Gibson, MD, Franco Locatelli, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2015) 126 (23): 563.

https://doi.org/10.1182/blood.V126.23.563.563

Published: 2015

Journal Articles

Clinical Impact of Additional Cytogenetic Aberrations and Complex Karyotype In Pediatric 11q23/ MLL -Rearranged AML: Results from an International Retrospective Study

Blood (2010) 116 (21): 762.

https://doi.org/10.1182/blood.V116.21.762.762

Published: 2010

Journal Articles

Myeloid Leukemia of Down Syndrome: The Results of An International Retrospective Study

Blood (2010) 116 (21): 2718.

https://doi.org/10.1182/blood.V116.21.2718.2718

Published: 2010

Journal Articles

Genetic and Epigenetic Events in Childhood AML - Similarities and Differences with Adult AML.

Caroline Juhl-Christensen, MD, PhD, Hans Beier Ommen, MD, PhD, Anni Aggerholm, PhD, Birgitte Lausen, MD, PhD, Eigil Kjeldsen, MD, Henrik Hasle, MD, PhD, Peter Hokland, MD, DMSc

Blood (2009) 114 (22): 2396.

https://doi.org/10.1182/blood.V114.22.2396.2396

Published: 2009

Journal Articles

Mutation Analysis of JAK-1, 2 and 3 in Children with Down Syndrome and Acute Leukemia.

Marjolein Blink, MD, Trudy Buitenkamp, MSc, Astrid A Danen-van Oorschot, PhD, Valerie de Haas, MD, PhD, Dirk Reinhardt, MD, PhD, Henrik Hasle, MD, PhD, Marry M. van den Heuvel, MD, PhD, C. Michel Zwaan, MD, PhD

Blood (2009) 114 (22): 5035.

https://doi.org/10.1182/blood.V114.22.5035.5035

Published: 2009

Journal Articles

High Frequency of Copy Number Variations in Myeloid Leukemia of Down Syndrome.

Marjolein Blink, MD, Marry M van den Heuvel-Eibrink, MD, PhD, Brian Balgobind, MD, Iris H.I.M. Hollink, MD, Valerie de Haas, MD, PhD, Gertjan Kaspers, MD, PhD, Dirk Reinhardt, MD, PhD, Henrik Hasle, MD, PhD, C. Michel Zwaan, MD, PhD

Blood (2009) 114 (22): 3242.

https://doi.org/10.1182/blood.V114.22.3242.3242

Published: 2009

Journal Articles

Subcutaneous (sc) Anti-D Treatment of Childhood Idiopathic Thrombocytopenic Purpura (ITP).

Mimi Kjaersgaard, MD, Pernille W. Edslev, MD, Henrik Hasle, MD, PhD

Blood (2007) 110 (11): 1312.

https://doi.org/10.1182/blood.V110.11.1312.1312

Published: 2007

Journal Articles

Impaired CD163 Mediated Hemoglobin-Scavenging and Hemolytic Crisis in Patients Treated with CD33 Targeted Chemotherapy (Gemtuzumab Ozogamicin, Mylotarg™).

Maciej B. Maniecki, MHSc, Henrik Hasle, MD, PHD, Lennart Friis-Hansen, MD, PHD, Birgitte Lausen, MD, PHD, Ove J. Nielsen, MD, PHD, Knud Bendix, MD, PHD, Soren K. Moestrup, MD, PHD, Holger J. Moller, MD, PHD

Blood (2007) 110 (11): 3684.

https://doi.org/10.1182/blood.V110.11.3684.3684

Published: 2007

Journal Articles

Subcutaneous Anti-D as Treatment of Idiopathic Thrombocytopenic Purpura in Children; Clinical Observations.

Mimi Kjaersgaard, MD, Henrik Hasle, MD, PhD

Blood (2005) 106 (11): 3998.

https://doi.org/10.1182/blood.V106.11.3998.3998

Published: 2005

Journal Articles

The Prognostic Impact of Blast Cell Immunophenotyping in Intermediate Risk AML Patients at Diagnosis.

Marianne H. Hoffmann, MD, Eva B. Leinoe, MD, Tobias W. Klausen, MS, Ronnie C. Danielsen, Erik Kjaersgaard, MS, Kjeld Schmiegelow, MD DMSc, Henrik Hasle, MD PhD, Nina Hastrup, MD, Jorgen S. Kristensen, MD DMSc, Inge H. Dufva, MD, Niels E. Hansen, MD DMSc, Olav J. Bergmann, MD DMSc, Hans E. Johnsen, MD DMSc

Blood (2004) 104 (11): 2990.

https://doi.org/10.1182/blood.V104.11.2990.2990

Published: 2004

NARROW

Systematic Assessment of GATA2 Genetic Variation Reveals the Presence of Novel Disease-Causing Synonymous Exonic Mutations

Differences in Infection Prophylaxis between Pediatric AML Study Groups within the International BFM Study Group

Constitutional Ring Chromosome 21 Predisposes to Acute Lymphoblastic Leukaemia (ALL) with iAMP21

Constitutional SAMD9L Mutations Cause Familial Myelodisplastic Syndrome with Monosomy 7 and Stable Revertant Mosaicism

Characteristics and Outcomes of Pediatric Patients with t(16;16)-AML: Results of a Case Series By the International BFM Study Group

Obesity Is Associated with Favorable Cytogenetic Abnormalities in Pediatric Acute Myeloid Leukemia

Effect of Age and Weight on Toxicity and Survival in Pediatric Acute Myeloid Leukemia

Predictors of Early Death in Childhood Acute Promyelocytic Leukemia: Results of an International Retrospective Study

Risk-Group Stratified and Minimal Residual Disease (MRD)-Guided Treatment with Extended ATRA and Reduced-Anthracycline Chemotherapy in Childhood Acute Promyelocytic Leukemia (APL): Results from ICC APL Study 01 (NCT01226303; EudraCT 2008-002311-40)

Clinical Impact of Additional Cytogenetic Aberrations and Complex Karyotype In Pediatric 11q23/ MLL -Rearranged AML: Results from an International Retrospective Study

Myeloid Leukemia of Down Syndrome: The Results of An International Retrospective Study

Genetic and Epigenetic Events in Childhood AML - Similarities and Differences with Adult AML.

Mutation Analysis of JAK-1, 2 and 3 in Children with Down Syndrome and Acute Leukemia.

High Frequency of Copy Number Variations in Myeloid Leukemia of Down Syndrome.

Subcutaneous (sc) Anti-D Treatment of Childhood Idiopathic Thrombocytopenic Purpura (ITP).

Impaired CD163 Mediated Hemoglobin-Scavenging and Hemolytic Crisis in Patients Treated with CD33 Targeted Chemotherapy (Gemtuzumab Ozogamicin, Mylotarg™).

Subcutaneous Anti-D as Treatment of Idiopathic Thrombocytopenic Purpura in Children; Clinical Observations.

The Prognostic Impact of Blast Cell Immunophenotyping in Intermediate Risk AML Patients at Diagnosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only